ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Applying to Saint Luke's Cancer Institute - Meridian · Meridian, Idaho
Answer a few short questions to share with the research team.